杀手细胞免疫球蛋白类受体多态性与COVID-19结局有关:试点观察研究结果
J E Niño-Ramírez1, M Alcoceba1, M N Gutiérrez-Zufiaurre2
1Laboratorio de HLA-Biología Molecular, Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), CIBERONC, Centro de Investigación del Cáncer (CIC) and Universidad de Salamanca (USAL), Salamanca, Spain.
HLA
|August 16, 2024
概括
杀手细胞免疫球蛋白样受体 (KIR) 和HLA基因变异影响COVID-19的严重程度. 一些KIR基因型,如AA,提供保护,而另一些则表明更高的风险,有助于预测严重疾病的结果.
科学领域:
- 免疫遗传学 免疫遗传学
- 传染病流行病学 传染病流行病学
- 基因组医学是基因组医学.
背景情况:
- COVID-19结果的变化需要了解影响疾病发病的宿主遗传因素.
- 杀手细胞免疫球蛋白样受体 (KIR) 和人类白细胞抗原 (HLA) 基因在免疫反应中起着至关重要的作用,可能会影响SARS-CoV-2感染的易感性和严重性.
研究的目的:
- 研究KIR和HLA基因多态化与COVID-19的易感性,进展和严重程度之间的关联.
- 为了确定潜在的遗传生物标志物来预测严重的COVID-19结果.
主要方法:
- 这是一项追溯观察性研究,涉及458名COVID-19患者和667名对照组.
- 使用Luminex®技术对HLA-A, -B, -C和KIR基因进行基因定型.
- 多变量二进制后勤回归和ROC分析,以评估严重COVID-19的遗传变异的预测价值.
主要成果:
- KIR AA基因型表现出对严重的COVID-19有保护作用.
- 特定的KIR基因 (KIR3DL1,KIR2DL3,KIR2DS4) 与保护有关,而其他基因 (KIR Bx基因型,KIR2DL2,KIR2DS2,KIR2DS3,KIR3DS1) 被确定为严重疾病的生物标志物.
- 一个包含临床和遗传变量的后勤回归模型准确预测了严重COVID-19的高/低风险 (Se=94.29%,Sp=84.55%).
结论:
- 基尔/HLA连接物多态性与不同的COVID-19临床结果显著相关.
- 这些遗传多态化可以作为潜在的替代生物标志物,用于早期识别患有严重COVID-19高风险的患者.
- 这一发现为未来传染病爆发的风险分层和管理策略带来了希望.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K


